ABBOTT FDA Approval ANDA 084222

ANDA 084222

ABBOTT

FDA Drug Application

Application #084222

Application Sponsors

ANDA 084222ABBOTT

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION50MG/ML0PROMETHAZINE HYDROCHLORIDEPROMETHAZINE HYDROCHLORIDE

CDER Filings

ABBOTT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84222
            [companyName] => ABBOTT
            [docInserts] => ["",""]
            [products] => [{"drugName":"PROMETHAZINE HYDROCHLORIDE","activeIngredients":"PROMETHAZINE HYDROCHLORIDE","strength":"50MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PROMETHAZINE HYDROCHLORIDE","submission":"PROMETHAZINE HYDROCHLORIDE","actionType":"50MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.